Australia - engelsk - Department of Health (Therapeutic Goods Administration)

mundipharma pty ltd - timolol maleate, quantity: 3.42 mg/ml (equivalent: timolol, qty 2.5 mg/ml) - eye drops, solution - excipient ingredients: benzalkonium chloride; monobasic sodium phosphate; dibasic sodium phosphate dodecahydrate; water for injections; sodium hydroxide - timoptol ophthalmic solution is indicated for the reduction of elevated intraocular pressure. in clinical trials it has been shown to reduce intraocular pressure in: patients with ocular hypertension - patients with chronic open-angle glaucoma - aphakic patients with glaucoma.

Australia - engelsk - Department of Health (Therapeutic Goods Administration)

mundipharma pty ltd - timolol maleate, quantity: 6.83 mg/ml (equivalent: timolol, qty 5 mg/ml) - eye drops, solution - excipient ingredients: monobasic sodium phosphate; dibasic sodium phosphate dodecahydrate; sodium hydroxide; benzalkonium chloride; water for injections - timoptol ophthalmic solution is indicated for the reduction of elevated intraocular pressure. in clinical trials it has been shown to reduce intraocular pressure in: patients with ocular hypertension - patients with chronic open-angle glaucoma - aphakic patients with glaucoma.

Australia - engelsk - Department of Health (Therapeutic Goods Administration)

mundipharma pty ltd - timolol maleate, quantity: 6.84 mg/ml (equivalent: timolol, qty 5 mg) - eye drops, solution - excipient ingredients: mannitol; gellan gum; benzododecinium bromide; water for injections; trometamol - other storage conditions: do not freeze. indications: for the reduction of elevated intraocular pressure in patients with: ocular hypertension; chronic open-angle glaucoma; aphakia and glaucoma.

Australia - engelsk - Department of Health (Therapeutic Goods Administration)

mundipharma pty ltd - timolol maleate, quantity: 3.42 mg/ml (equivalent: timolol, qty 2.5 mg) - eye drops, solution - excipient ingredients: gellan gum; water for injections; benzododecinium bromide; trometamol; mannitol - indications: for the reduction of elevated intraocular pressure in patients with: ocular hypertension; chronic open-angle glaucoma; aphakia and glaucoma.

New Zealand - engelsk - Medsafe (Medicines Safety Authority)

mundipharma new zealand ltd - timolol maleate 3.42 mg/ml equivalent to 2.5 mg/ml timolol - eye drops, solution - 0.25 % - active: timolol maleate 3.42 mg/ml equivalent to 2.5 mg/ml timolol excipient: benzalkonium chloride as 17% solution dibasic sodium phosphate monobasic sodium phosphate dihydrate sodium hydroxide as 1n solution to ph 6.8-7.0 water for injection

New Zealand - engelsk - Medsafe (Medicines Safety Authority)

mundipharma new zealand ltd - timolol maleate 6.84 mg/ml equivalent to 5 mg/ml timolol - eye drops, solution - 0.5 % - active: timolol maleate 6.84 mg/ml equivalent to 5 mg/ml timolol excipient: benzalkonium chloride as 17% solution dibasic sodium phosphate monobasic sodium phosphate monohydrate sodium hydroxide as 1n solution to ph 6.8-7.0 water for injection

Australia - engelsk - Department of Health (Therapeutic Goods Administration)

merck sharp & dohme australia pty ltd - timolol maleate -

Brasil - portugisisk - ANVISA (Agência Nacional de Vigilância Sanitária)

mundipharma brasil produtos mÉdicos e farmacÊuticos ltda - maleato de timolol - antiglaucomatosos

Brasil - portugisisk - ANVISA (Agência Nacional de Vigilância Sanitária)

organon farmacÊutica ltda. - antiglaucomatosos

Frankrike - fransk - ANSM (Agence Nationale de Sécurité du Médicament et des Produits de Santé)

laboratoires santen oy - timolol base 0 - collyre - 0,500 g - pour 100 ml de collyre en solution > timolol base 0,500 g sous forme de : maléate de timolol 0,683 g - antiglaucomateux - classe pharmacothérapeutique : antiglaucomateux – code atc : s01ed01ce médicament est indiqué dans le traitement de certaines maladies de l'œil comportant une hypertension intra-oculaire (glaucome, hypertonie intra-oculaire).